ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEPHEN GORMAN M.D.

Internal Medicine

436

$118K

98
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$271
Average prescription price

Avg: $63

PETER GUNTHER M.D.

Internal Medicine

4,284

$469K

284
217 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $63

MARK PASANEN MD

Internal Medicine

5,204

$514K

328
174 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $63

ROBERT WOOD M.D.

Internal Medicine

2,659

$263K

168
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $63

HALLE SOBEL MD

Internal Medicine

1,644

$155K

151
81 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $63

RICHARD PINCKNEY MD

Internal Medicine

1,762

$163K

349
219 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$93
Average prescription price

Avg: $63

MELISSA BRANDES M.D.

Internal Medicine

3,492

$320K

184
136 are 65+

21%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $63

JEFFREY STALL M.D.

Internal Medicine

5,219

$466K

205
127 are 65+

20%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $63

CHRISTOPHER RICKMAN MD

Internal Medicine

10,564

$921K

321
248 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $63

ERIC POFCHER M.D.

Internal Medicine

1,482

$122K

206
130 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $63

LAURA METSCH MD

Internal Medicine

2,898

$237K

213
157 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $63

JASON GRAMLING MD

Internal Medicine

3,475

$283K

231
193 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $63

CLAUDIA BERGER MD

Internal Medicine

3,073

$244K

229
162 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$79
Average prescription price

Avg: $63

LORISSA SEGAL M.D.

Internal Medicine

2,101

$164K

193
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$78
Average prescription price

Avg: $63

MICHAEL CORRIGAN MD

Internal Medicine

8,260

$635K

330
186 are 65+

22%
patients receiving schedule two controlled substances

Avg: 10%

18%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $63

ANNE BRENA MD

Internal Medicine

5,329

$408K

357
180 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $63

MARK LEVINE MD

Internal Medicine

1,517

$116K

128
91 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $63

CHRISTINE NORTHRUP MD

Internal Medicine

1,718

$129K

86
78 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $63

DENNIS BEATTY M.D.

Internal Medicine

3,654

$274K

291
234 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $63

JENNIFER AYER MD

Internal Medicine

1,386

$103K

156
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $63

JOHN MATTHEW M.D.

Internal Medicine

4,727

$349K

198
120 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $63

ROBERT ZELAZO MD

Internal Medicine

8,243

$601K

311
229 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

SHEILA KENDRICK MD

Internal Medicine

2,542

$185K

113
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

PETER STICKNEY MD

Internal Medicine

11,924

$864K

428
368 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

MARLENE SACHS MD

Internal Medicine

3,488

$252K

212
173 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank